EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Exploiting radiation immunostimulatory effects to improve glioblastoma outcome

Hala Awada, François Paris iD, Claire Pecqueur iD

Neuro-Oncology · 2023

DOI: 10.1093/neuonc/noac239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, 2023. Verfasst von Hala Awada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nantes Université, CRCI2NA, INSERM, CNRS, F-44000 Nantes, France. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Radiation Injuries. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ERASMUS, SAFAR, ARC Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer treatment protocols depend on tumor type, localization, grade, and patient. Despite aggressive treatments, median survival of patients with Glioblastoma (GBM), the most common primary brain tumor in adults, does not exceed 18 months, and all patients eventually relapse. Thus, novel therapeutic approaches are urgently needed. Radiotherapy (RT) induces a multitude of alterations within the tumor ecosystem, ultimately modifying the degree of tumor immunogenicity at GBM relapse. The present manuscript reviews the diverse effects of RT radiotherapy on tumors, with a special focus on its immunomodulatory impact to finally discuss how RT could be exploited in GBM treatment through immunotherapy targeting. Indeed, while further experimental and clinical studies are definitively required to successfully translate preclinical results in clinical trials, current studies highlight the therapeutic potential of immunotherapy to uncover novel avenues to fight GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsRadiation InjuriesAdultHumansEcosystemNeoplasm Recurrence, LocalImmunotherapy

Stichwörter der Autor:innen

glioblastomaimmunomodulationradiotherapy

Autor:innen und Institutionen

  • Nantes Université, CRCI2NA, INSERM, CNRS, F-44000 Nantes, France.
  • Anti-Tumor Therapeutic Targeting Laboratory, Faculty of Sciences, Lebanese University, Hadath, Beirut, Lebanon.
  • Institut de Cancérologie de l'Ouest, Saint-Herblain, France.

ORCID-Profile: François Paris, Claire Pecqueur

Förderung

  • ERASMUS
  • SAFAR
  • ARC Foundation
  • Ligue contre le Cancer

Zitieren

APA

Awada, H., Paris, F., & Pecqueur, C. (2023). Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Neuro-Oncology. https://doi.org/10.1093/neuonc/noac239

Vancouver

Awada H, Paris F, Pecqueur C. Exploiting radiation immunostimulatory effects to improve glioblastoma outcome. Neuro-Oncology. 2023. doi:10.1093/neuonc/noac239

BibTeX
@article{Awada2023,
  author = {Awada, Hala and Paris, François and Pecqueur, Claire},
  title = {Exploiting radiation immunostimulatory effects to improve glioblastoma outcome},
  journal = {Neuro-Oncology},
  year = {2023},
  doi = {10.1093/neuonc/noac239}
}
Kostenlos starten →